Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis
- PMID: 28412063
- DOI: 10.1016/j.eururo.2017.03.042
Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis
Abstract
Context: Magnetic resonance imaging (MRI) has been tested for detecting bone metastasis and has shown promising results. Yet, consensus has not been reached regarding whether it can replace the role of bone scintigraphy in this clinical setting or not.
Objective: To review the diagnostic performance of contemporary (≥1.5 T) MRI for the detection of bone metastasis in patients with prostate cancer.
Evidence acquisition: MEDLINE and EMBASE were searched up to January 22, 2017. We included studies that used MRI using ≥1.5-T scanners for the detection of bone metastasis in patients with prostate cancer, using histopathology or best value comparator as the reference standard. Two independent reviewers assessed the methodological quality using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Per-patient sensitivity and specificity of included studies were calculated, and pooled and plotted in a hierarchical summary receiver operating characteristic plot. Meta-regression and sensitivity analyses were performed.
Evidence synthesis: Ten studies (1031 patients) were included. Pooled sensitivity was 0.96 (95% confidence interval [CI] 0.87-0.99) with a specificity of 0.98 (95% CI 0.93-0.99). At meta-regression analysis, only the number of imaging planes (≥2 vs 1) was a significant factor affecting heterogeneity (p<0.01). Sensitivity analyses showed that specificity estimates were comparable and consistently high across all subgroups, but sensitivity estimates demonstrated some differences. Studies using two or more planes (n=4) had the highest sensitivity (0.99 [95% CI 0.98-1.00]).
Conclusions: Contemporary MRI shows excellent sensitivity and specificity for detection of bone metastasis in patients with prostate cancer. Using two or more imaging planes may further improve sensitivity. However, caution is needed in applying our results due to the heterogeneity among the included studies.
Patient summary: We reviewed studies using contemporary magnetic resonance imaging (MRI) for the detection of bone metastasis in prostate cancer patients. MRI shows excellent diagnostic performance in finding patients with bone metastasis.
Keywords: Bone metastasis; Magnetic resonance imaging; Meta-analysis; Prostate cancer; Systematic review.
Copyright © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.03.042.Eur Urol. 2017 Oct;72(4):e98-e99. doi: 10.1016/j.eururo.2017.05.035. Epub 2017 May 29. Eur Urol. 2017. PMID: 28571882 No abstract available.
-
Reply to Thorsten Derlin, Christoph-A. von Klot, and Katja Hueper's Letter to the Editor re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.03.042.Eur Urol. 2017 Oct;72(4):e100-e101. doi: 10.1016/j.eururo.2017.05.036. Epub 2017 May 31. Eur Urol. 2017. PMID: 28576505 No abstract available.
-
Magnetic Resonance Imaging and Detection of Metastases in Prostate Cancer: Learning Lessons from History.Eur Urol. 2018 Jan;73(1):92-93. doi: 10.1016/j.eururo.2017.05.052. Epub 2017 Jun 8. Eur Urol. 2018. PMID: 28602204 No abstract available.
-
Reply to Jae Heon Kim, Bora Lee, and Benjamin I. Chung's Letter to the Editor re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.03.042.Eur Urol. 2017 Dec;72(6):e166-e167. doi: 10.1016/j.eururo.2017.06.025. Epub 2017 Jul 5. Eur Urol. 2017. PMID: 28688611 No abstract available.
-
Re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.03.042.Eur Urol. 2017 Dec;72(6):e164-e165. doi: 10.1016/j.eururo.2017.06.024. Epub 2017 Jul 6. Eur Urol. 2017. PMID: 28689900 No abstract available.
Similar articles
-
Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis.Eur Urol. 2017 Aug;72(2):177-188. doi: 10.1016/j.eururo.2017.01.042. Epub 2017 Feb 11. Eur Urol. 2017. PMID: 28196723
-
The Diagnostic Performance of MRI for Detection of Lymph Node Metastasis in Bladder and Prostate Cancer: An Updated Systematic Review and Diagnostic Meta-Analysis.AJR Am J Roentgenol. 2018 Mar;210(3):W95-W109. doi: 10.2214/AJR.17.18481. Epub 2018 Jan 30. AJR Am J Roentgenol. 2018. PMID: 29381380
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2. Cochrane Database Syst Rev. 2022. PMID: 35521901 Free PMC article.
Cited by
-
Improved Diagnostic Accuracy of Bone Metastasis Detection by Water-HAP Associated to Non-contrast CT.Diagnostics (Basel). 2020 Oct 20;10(10):853. doi: 10.3390/diagnostics10100853. Diagnostics (Basel). 2020. PMID: 33092274 Free PMC article.
-
68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study.Eur Radiol. 2019 Mar;29(3):1221-1230. doi: 10.1007/s00330-018-5682-x. Epub 2018 Aug 21. Eur Radiol. 2019. PMID: 30132104
-
Comparison of whole-body bone scintigraphy with axial skeleton magnetic resonance imaging in the skeletal evaluation of carcinoma prostate.Indian J Urol. 2021 Jan-Mar;37(1):72-78. doi: 10.4103/iju.IJU_238_20. Epub 2021 Jan 1. Indian J Urol. 2021. PMID: 33850359 Free PMC article.
-
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway.Front Oncol. 2020 Jul 30;10:1141. doi: 10.3389/fonc.2020.01141. eCollection 2020. Front Oncol. 2020. PMID: 32850324 Free PMC article.
-
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer.Cancer Res Commun. 2022 Mar 21;2(3):172-181. doi: 10.1158/2767-9764.CRC-21-0183. eCollection 2022 Mar. Cancer Res Commun. 2022. PMID: 36874403 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical